glp-1 market size 2023 Agonists Size, Share, Growth Insights 2032 How to Invest in GLP-1

Blue Cross Blue Shield of Michigan eliminated Wegovy, Zepbound, and Saxenda for fully insured large groups at renewals that began in January 2025 thousands have already lost coverage

That includes slowing how quickly food leaves the stomach, prompting the pancreas to release insulin when blood sugar is high and suppressing the release of a hormone that raises blood sugar

Additionally, GLP-1 slows down the rate at which food leaves the stomach, contributing to a feeling of fullness that can help manage appetite

Download the Shot-Day Survival Kit and make your next shot weekend feel lighter, calmer, and more manageable

Individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or known allergies to any component of Tirzepatide are not candidates for this therapy